These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31728561)

  • 1. Genetic association between IL23R rs11209026 and rs10889677 polymorphisms and risk of Crohn's disease and ulcerative colitis: evidence from 41 studies.
    Zhu Y; Jiang H; Chen Z; Lu B; Li J; Shen X
    Inflamm Res; 2020 Jan; 69(1):87-103. PubMed ID: 31728561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease.
    Roberts RL; Gearry RB; Hollis-Moffatt JE; Miller AL; Reid J; Abkevich V; Timms KM; Gutin A; Lanchbury JS; Merriman TR; Barclay ML; Kennedy MA
    Am J Gastroenterol; 2007 Dec; 102(12):2754-61. PubMed ID: 17894849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands.
    Weersma RK; Zhernakova A; Nolte IM; Lefebvre C; Rioux JD; Mulder F; van Dullemen HM; Kleibeuker JH; Wijmenga C; Dijkstra G
    Am J Gastroenterol; 2008 Mar; 103(3):621-7. PubMed ID: 18047540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the interleukin-23 receptor gene variant rs11209026 with Crohn's disease in German children.
    Lacher M; Schroepf S; Helmbrecht J; Von Schweinitz D; Ballauff A; Koch I; Lohse P; Osterrieder S; Kappler R; Koletzko S
    Acta Paediatr; 2010 May; 99(5):727-733. PubMed ID: 20192940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of IL23R, JAK2, and STAT3 gene polymorphisms and gene-gene interactions in Crohn's disease and ulcerative colitis in a Turkish population.
    Can G; Tezel A; Gürkan H; Tozkır H; Ünsal G; Soylu AR; Ümit HC
    Turk J Gastroenterol; 2016 Nov; 27(6):525-536. PubMed ID: 27852544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-23 receptor genetic polymorphisms and ulcerative colitis susceptibility: A meta-analysis.
    Liu M; Zhu W; Wang J; Zhang J; Guo X; Wang J; Song J; Dong W
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):516-25. PubMed ID: 25497273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction.
    Márquez A; Mendoza JL; Taxonera C; Díaz-Rubio M; De La Concha EG; Urcelay E; Martínez A
    Inflamm Bowel Dis; 2008 Sep; 14(9):1192-6. PubMed ID: 18383521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-23R mutation is associated with ulcerative colitis: A systemic review and meta-analysis.
    Peng LL; Wang Y; Zhu FL; Xu WD; Ji XL; Ni J
    Oncotarget; 2017 Jan; 8(3):4849-4863. PubMed ID: 27902482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Fischer S; Kövesdi E; Magyari L; Csöngei V; Hadzsiev K; Melegh B; Hegyi P; Sarlós P
    World J Gastroenterol; 2017 Jan; 23(3):447-454. PubMed ID: 28210080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis.
    Büning C; Schmidt HH; Molnar T; De Jong DJ; Fiedler T; Bühner S; Sturm A; Baumgart DC; Nagy F; Lonovics J; Drenth JP; Landt O; Nickel R; Büttner J; Lochs H; Witt H
    Aliment Pharmacol Ther; 2007 Oct; 26(7):1025-33. PubMed ID: 17877509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions.
    Okazaki T; Wang MH; Rawsthorne P; Sargent M; Datta LW; Shugart YY; Bernstein CN; Brant SR
    Inflamm Bowel Dis; 2008 Nov; 14(11):1528-41. PubMed ID: 18521914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.
    Glas J; Seiderer J; Wetzke M; Konrad A; Török HP; Schmechel S; Tonenchi L; Grassl C; Dambacher J; Pfennig S; Maier K; Griga T; Klein W; Epplen JT; Schiemann U; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Folwaczny M; Mussack T; Brand S
    PLoS One; 2007 Sep; 2(9):e819. PubMed ID: 17786191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease.
    Sventoraityte J; Zvirbliene A; Franke A; Kwiatkowski R; Kiudelis G; Kupcinskas L; Schreiber S
    World J Gastroenterol; 2010 Jan; 16(3):359-64. PubMed ID: 20082483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population.
    Lappalainen M; Halme L; Turunen U; Saavalainen P; Einarsdottir E; Färkkilä M; Kontula K; Paavola-Sakki P
    Inflamm Bowel Dis; 2008 Aug; 14(8):1118-24. PubMed ID: 18338763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype.
    Cummings JR; Ahmad T; Geremia A; Beckly J; Cooney R; Hancock L; Pathan S; Guo C; Cardon LR; Jewell DP
    Inflamm Bowel Dis; 2007 Sep; 13(9):1063-8. PubMed ID: 17508420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between TNFSF15 and IL23R with ulcerative colitis in Koreans.
    Yang SK; Jung Y; Hong M; Kim H; Ye BD; Lee I; Song K
    J Hum Genet; 2011 Mar; 56(3):200-4. PubMed ID: 21228792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism rs6478109 in the
    Zhou Y; Zhu Y; Jiang H; Chen Z; Lu B; Li J; Shen X
    J Int Med Res; 2020 Oct; 48(10):300060520961675. PubMed ID: 33026276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of the relationship between MYO9B gene polymorphisms and susceptibility to Crohn's disease and ulcerative colitis.
    Li P; Yang XK; Wang X; Zhao MQ; Zhang C; Tao SS; Zhao W; Huang Q; Li LJ; Pan HF; Ye DQ
    Hum Immunol; 2016 Oct; 77(10):990-996. PubMed ID: 27435931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease.
    Tremelling M; Cummings F; Fisher SA; Mansfield J; Gwilliam R; Keniry A; Nimmo ER; Drummond H; Onnie CM; Prescott NJ; Sanderson J; Bredin F; Berzuini C; Forbes A; Lewis CM; Cardon L; Deloukas P; Jewell D; Mathew CG; Parkes M; Satsangi J
    Gastroenterology; 2007 May; 132(5):1657-64. PubMed ID: 17484863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.